UBT251 clinical trials
Also written UBT251.
How each study uses UBT251 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the UBT251 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2026 (10)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 10 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 0
The United Bio-Technology (Hengqin) Co., Ltd. (8) · Novo Nordisk A/S (4)
Often tested with
Tested in the same studies.
Contraceptives, Oral (1) · Acetaminophen (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 8, 2 in phase 3
Studies that test UBT251, phase 3 first.
- Sep 2027Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)Phase 3 · The United Bio-Technology (Hengqin) Co., Ltd.
- Sep 2027UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)Phase 3 · The United Bio-Technology (Hengqin) Co., Ltd.
- Dec 2026Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityPhase 1 · The United Bio-Technology (Hengqin) Co., Ltd.
- Jan 2027A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityPhase 2 · Novo Nordisk A/S
- Apr 2027A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body WeightPhase 1 · Novo Nordisk A/S
- Apr 2027A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become PregnantPhase 1 · Novo Nordisk A/S
- Jun 2027A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)Phase 2 · The United Bio-Technology (Hengqin) Co., Ltd.
- Oct 2027A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesPhase 2 · Novo Nordisk A/S
Studies
Open first, then newest update. How each study uses UBT251 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- UBT251 Injection Phase Ⅲ Study (OSA-NPAP)Not yet recruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07767942Written as UBT251
- UBT251 Injection Phase II Clinical Study (CKD)RecruitingPhase 2The United Bio-Technology (Hengqin) Co., Ltd.NCT07134335Written as UBT251
- A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)RecruitingPhase 2The United Bio-Technology (Hengqin) Co., Ltd.NCT07145151Written as UBT251
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesRecruitingPhase 2Novo Nordisk A/SNCT07668388Written as UBT251
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)RecruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07659574Written as UBT251 Injection 2.0 mg
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)RecruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07653477Written as UBT251 Injection 2.0 mg group
- UBT251 Injection Phase Ⅲ Study (OSA-PAP)Not yet recruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07806851Written as UBT251
- A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become PregnantRecruitingPhase 1Novo Nordisk A/SNCT07710729Written as UBT251
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07785934Written as UBT251
- A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body WeightRecruitingPhase 1Novo Nordisk A/SNCT07710768Written as UBT251
- A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityRecruitingPhase 2Novo Nordisk A/SNCT07395687Written as UBT251
- UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)Active, not recruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07648225Written as UBT251 Injection 4.0 mg